Board of Directors
	Saul Kent Chairman Mr. Kent is a founder of BioMarker. He also founded Life Extension Foundation, a successful non-profit organization, which has been a benefactor of anti-aging research for many years. Mr. Kent serves as a Director of the Life Extension Foundation, which provides cutting-edge information and nutrient products to its over 120,000 members. The Foundation also funds groundbreaking life extension research, publishes new information about improving health and extending life span, and funds anti-aging cryopreservation and resuscitation research. Mr. Kent is a founder of two other research companies: 21st Century Medicine and Critical Care Research.
	Victor V. Vurpillat Ph.D., MBA Vice President, Corporate Affairs, Director Dr. Vurpillat is a founder of BioMarker. Dr. Vurpillat has been involved with biotech companies for nearly a decade, serving as CEO of Transgenic Technologies, Inc. a start-up in genetic research. He was a founder, officer or director of sixteen early-stage companies including Novell, Telerate, Optogenetics, LV Computer Systems, Compucom, Spear Information Systems, InCell, IDR-Reuters and Spanworks Inc. Dr. Vurpillat holds a Ph.D. in organizational behavior from Newport University, an MBA from Pepperdine University and a B.S. in Math from California Polytechnic University.
	Xi Zhao-Wilson, Ph.D., MBA Chief Executive Officer, Founder, Director Dr. Zhao-Wilson has more than 15 years experience as a senior executive of start-up, early stage and established companies in the biotech industry. She was a corporate development executive at Aviron, a biopharmaceutical company that recently merged with MedImmune. She was a founder and CEO of InCell, a biomedical company. Dr. Zhao-Wilson served as board director and senior executive officer at Baekon, a biotech company. Dr. Zhao-Wilson is Professor at the Chinese Academy of Preventative Medicine in Beijing. As a Research Scientist at Stanford Medical Center, she conducted research focused on gene regulation in various cancers that are related to steroid hormone receptors. Dr. Zhao-Wilson received her M.S. in molecular genetics and Cell Biology from the Institute of Cell Biology, Chinese Academy of Sciences, and her Ph.D. in Cellular and Developmental Biology from The Ohio State University. Her MBA, from Fisher School of Business, MIIS focused on international business management. Dr. Zhao-Wilson has been awarded four U.S. patents and has published numerous research articles and book chapters. She has successfully obtained research funding through an SBIR Grant from the U.S. Department of Health and Human Services and an award from the Katharine McCormick Fund. She has also lectured extensively at international research institutions including the U.S. National Institutes of Health, the Max-Planck-Institute in Germany and at numerous universities in the U.S., China, and European countries.

Back to top